PAREXEL International Corporation  

(Public, NASDAQ:PRXL)   Watch this stock  
Find more results for PRXL
70.14
+0.19 (0.27%)
Sep 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 69.43 - 70.37
52 week 56.00 - 71.13
Open 69.49
Vol / Avg. 435,070.00/416,620.00
Mkt cap 3.74B
P/E 24.44
Div/yield     -
EPS 2.87
Shares 52.90M
Beta 0.95
Inst. own 101%
Dec 2, 2016
PAREXEL International Corp Annual Shareholders Meeting (Estimated) - 2:30PM EST - Add to calendar
Oct 26, 2016
Q1 2017 PAREXEL International Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 15, 2016
PAREXEL International Corp at Credit Suisse Small & Mid Cap Conference
Sep 7, 2016
PAREXEL International Corp at Wells Fargo Securities Healthcare Conference
Aug 4, 2016
Q4 2016 PAREXEL International Corp Earnings Call - Webcast
Aug 3, 2016
Q4 2016 PAREXEL International Corp Earnings Release
Jun 30, 2016
PAREXEL International Corp Investor Day Webcast - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 6.83% 6.38%
Operating margin 10.26% 9.23%
EBITD margin - 14.57%
Return on average assets 8.30% 7.94%
Return on average equity 27.75% 23.85%
Employees 18,600 -
CDP Score - 80 E

Address

195 West St
WALTHAM, MA 02451-1111
United States - Map
+1-781-4879900 (Phone)
+1-781-4870525 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management, data management, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, medical imaging services, electronic data capture systems, clinical trial management systems, Web-based portals, and other product development tools and services.

Officers and directors

Josef H. von Rickenbach Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Mark A. Goldberg M.D. President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Emma Reeve Interim Chief Financial Officer, Corporate Vice President, Controller
Age: 55
Bio & Compensation  - Reuters
Xavier AB Flinois President - PAREXEL Informatics
Age: 53
Bio & Compensation  - Reuters
Ulf Schneider Ph.D. Chief Administrative Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Douglas Alexander Batt Senior Vice President, General Counsel, Secretary
Age: 55
Bio & Compensation  - Reuters
Roland Andersson Ph.d. Senior Vice President - Clinical Research Services
Age: 52
Bio & Compensation  - Reuters
Christian Dreger Ph.D. Senior Vice President - Parexel Access and Parexel Consulting
Bio & Compensation  - Reuters
Gadi Saarony Senior Vice President - Clinical Research Services
Age: 47
Bio & Compensation  - Reuters
Thomas Senderovitz M.D. Senior Vice President - Clinical Research Services
Age: 49
Bio & Compensation  - Reuters